264 related articles for article (PubMed ID: 25929447)
1. Ellagic Acid, a Dietary Polyphenol, Inhibits Tautomerase Activity of Human Macrophage Migration Inhibitory Factor and Its Pro-inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
Sarkar S; Siddiqui AA; Mazumder S; De R; Saha SJ; Banerjee C; Iqbal MS; Adhikari S; Alam A; Roy S; Bandyopadhyay U
J Agric Food Chem; 2015 May; 63(20):4988-98. PubMed ID: 25929447
[TBL] [Abstract][Full Text] [Related]
2. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
Chuang CC; Chuang YC; Chang WT; Chen CC; Hor LI; Huang AM; Choi PC; Wang CY; Tseng PC; Lin CF
BMC Immunol; 2010 Oct; 11():50. PubMed ID: 20939898
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
Zhang Y; Gu R; Jia J; Hou T; Zheng LT; Zhen X
Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1134-1144. PubMed ID: 27543936
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Robertson MJ; Cisneros JA; Krimmer SG; Jorgensen WL
ChemMedChem; 2018 Jun; 13(11):1092-1097. PubMed ID: 29575754
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
Orita M; Yamamoto S; Katayama N; Fujita S
Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
10. Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Kostevich VA; Sokolov AV; Grudinina NA; Zakharova ET; Samygina VR; Vasilyev VB
Biometals; 2015 Oct; 28(5):817-26. PubMed ID: 26091949
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
12. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
13. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
[TBL] [Abstract][Full Text] [Related]
15. Irregularities in enzyme assays: The case of macrophage migration inhibitory factor.
Cisneros JA; Robertson MJ; Valhondo M; Jorgensen WL
Bioorg Med Chem Lett; 2016 Jun; 26(12):2764-2767. PubMed ID: 27156768
[TBL] [Abstract][Full Text] [Related]
16. Human single-chain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity.
Tarasuk M; Poungpair O; Ungsupravate D; Bangphoomi K; Chaicumpa W; Yenchitsomanus PT
Int J Mol Med; 2014 Mar; 33(3):515-22. PubMed ID: 24424397
[TBL] [Abstract][Full Text] [Related]
17. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
[TBL] [Abstract][Full Text] [Related]
18. New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
Wang FF; Zhu LA; Zou YQ; Zheng H; Wilson A; Yang CD; Shen N; Wallace DJ; Weisman MH; Chen SL; Lu LJ
Arthritis Res Ther; 2012 May; 14(3):R103. PubMed ID: 22551315
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E is a MIF Inhibitor.
Hegde B; Vadnal P; Sanghavi J; Korde V; Kulkarni-Almeida AA; Dagia NM
Biochem Biophys Res Commun; 2012 Feb; 418(2):384-9. PubMed ID: 22281490
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells.
Cho ML; Moon YM; Heo YJ; Woo YJ; Ju JH; Park KS; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Mar; 123(1):21-30. PubMed ID: 19428548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
